Fjoralba Zeka
Overview
Explore the profile of Fjoralba Zeka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
284
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Van Goethem A, Deleu J, Yigit N, Everaert C, Moreno-Smith M, Vasudevan S, et al.
NAR Cancer
. 2023 Jan;
5(1):zcad002.
PMID: 36683916
Accurate assessment of treatment response and residual disease is indispensable for the evaluation of cancer treatment efficacy. However, performing tissue biopsies for longitudinal follow-up poses a major challenge in the...
2.
Zeka F, Decock A, Van Goethem A, Vanderheyden K, Demuynck F, Lammens T, et al.
JCI Insight
. 2018 Dec;
3(23).
PMID: 30518699
In this study, the circulating miRNome from diagnostic neuroblastoma serum was assessed for identification of noninvasive biomarkers with potential in monitoring metastatic disease. After determining the circulating neuroblastoma miRNome, 743...
3.
Zeka F, Vanderheyden K, Smet E, Cuvelier C, Mestdagh P, Vandesompele J
Sci Rep
. 2016 Feb;
6:21418.
PMID: 26898768
Fragmented RNA from formalin-fixed paraffin-embedded (FFPE) tissue is a known obstacle to gene expression analysis. In this study, the impact of RNA integrity, gene-specific reverse transcription and targeted cDNA preamplification...
4.
Zeka F, Mestdagh P, Vandesompele J
Methods Mol Biol
. 2015 Mar;
1296:85-102.
PMID: 25791593
MicroRNAs (miRNAs) are small non-coding RNA molecules that negatively regulate messenger RNA (mRNA) translation into protein. MiRNAs play a key role in gene expression regulation, and their involvement in disease...
5.
Rihani A, De Wilde B, Zeka F, Laureys G, Francotte N, Tonini G, et al.
PLoS One
. 2014 Dec;
9(12):e114696.
PMID: 25502557
Background: Neuroblastoma is a pediatric cancer that exhibits a wide clinical spectrum ranging from spontaneous regression in low-risk patients to fatal disease in high-risk patients. The identification of single nucleotide...
6.
Van Peer G, Lefever S, Anckaert J, Beckers A, Rihani A, Van Goethem A, et al.
Database (Oxford)
. 2014 Aug;
2014.
PMID: 25157074
Database Url: www.mirbasetracker.org.
7.
Lack of association between MDM2 promoter SNP309 and clinical outcome in patients with neuroblastoma
Rihani A, Van Maerken T, De Wilde B, Zeka F, Laureys G, Norga K, et al.
Pediatr Blood Cancer
. 2014 Jan;
61(10):1867-70.
PMID: 24391119
While a polymorphism located within the promoter region of the MDM2 proto-oncogene, SNP309 (T > G), has previously been associated with increased risk and aggressiveness of neuroblastoma and other tumor...
8.
Bustin S, Benes V, Garson J, Hellemans J, Huggett J, Kubista M, et al.
Nat Methods
. 2013 Nov;
10(11):1063-7.
PMID: 24173381
Two surveys of over 1,700 publications whose authors use quantitative real-time PCR (qPCR) reveal a lack of transparent and comprehensive reporting of essential technical information. Reporting standards are significantly improved...
9.
De Preter K, Mestdagh P, Vermeulen J, Zeka F, Naranjo A, Bray I, et al.
Clin Cancer Res
. 2011 Oct;
17(24):7684-92.
PMID: 22031095
Purpose: More accurate assessment of prognosis is important to further improve the choice of risk-related therapy in neuroblastoma (NB) patients. In this study, we aimed to establish and validate a...
10.
Grootaert C, Boon N, Zeka F, Vanhoecke B, Bracke M, Verstraete W, et al.
J Microbiol Methods
. 2011 Mar;
86(1):33-41.
PMID: 21443910
Recent developments in host-microbe research give rise to a growing demand for rapid and accurate methods to quantify bacterial adhesion to epithelial cells. Here, we describe a new flow cytometric...